Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin and morning light therapy for delayed sleep phase in adults with ADHD
NL-OMON46908Phase 4Completed
- Sponsor
- Parnassia Groep
- Start
- May 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of melatonin in attention deficit hyperactivity disorder (ADHD) and delayed sleep-wake phase disorder (DSPD) (3 arms), sponsored by Parnassia Groep. Primary endpoint: Phase advance of DLMO at Follow-up 1. Started May 2013; status: completed.
02
Drugs
melatonin
03
Conditions
attention deficit hyperactivity disorder (ADHD)delayed sleep-wake phase disorder (DSPD)
Beyond the preview
Go deeper on NL-OMON46908.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON46908.